Archive | June, 2011

Scientific rationale for biologics study design in PPMI

A presentation that was developed by the leaders of the Biologics Working Group to provide insight into the decisions that went into the biologics study design for PPMI is now available. Click here to download the presentation.

Continue reading...

New York Times features PPMI subjects and study leaders

The New York Times speaks with Dr. Todd Sherer, MJFF CEO, Dr. Ken Marek, PPMI PI, and Dr. Karen Jaffe, whose husband is volunteering for PPMI in her honor. The article focuses on how persons with Parkinson's are coping with their diagnosis and how research, like PPMI, may help to improve the treatment of the disease.

Continue reading...

Poster Presentation on PPMI Recruitment from the MDS 2011 Meeting

Claire Meunier, Associate Director of Clinical Trials Strategies at MJFF, presented an overview of recruitment strategies used for PPMI at the MDS 2011 International Congress in Toronto. Click here to view the poster.

Continue reading...

Biomarkers for Parkinson’s disease (Science Translational Medicine)

This publication, authored by MJFF CEO Todd Sherer, makes a case for why biomarkers are important tools to research, the challenges involved, and what it will take to develop them.

Continue reading...